Kelyniam Global, Inc. (KLYG)
USD 0.22
(22.22%)
USD 0.22
(22.22%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -218.47 Thousand USD | -123.94% |
| 2022 | -97.56 Thousand USD | -148.36% |
| 2021 | 201.74 Thousand USD | 43.0% |
| 2020 | 141.07 Thousand USD | 139.41% |
| 2019 | -357.95 Thousand USD | -2238.95% |
| 2018 | -15.3 Thousand USD | 78.9% |
| 2017 | -72.53 Thousand USD | -436.84% |
| 2016 | -13.51 Thousand USD | 66.19% |
| 2015 | -39.96 Thousand USD | -737.45% |
| 2014 | -4772.00 USD | -131.95% |
| 2013 | 14.93 Thousand USD | 0.0% |
| 2007 | -182.7 Thousand USD | -60.0% |
| 2006 | -114.18 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 88.37 Thousand USD | -54.94% |
| 2024 Q2 | 167.00 USD | -99.81% |
| 2023 Q1 | -113.08 Thousand USD | -436.25% |
| 2023 FY | -218.47 Thousand USD | -123.94% |
| 2023 Q2 | -163.49 Thousand USD | -44.57% |
| 2023 Q3 | -138 Thousand USD | 15.59% |
| 2023 Q4 | 196.11 Thousand USD | 242.11% |
| 2022 Q4 | 33.63 Thousand USD | 464.46% |
| 2022 Q2 | -93.71 Thousand USD | -231.72% |
| 2022 Q1 | -28.25 Thousand USD | -37.06% |
| 2022 FY | -97.56 Thousand USD | -148.36% |
| 2022 Q3 | -9228.00 USD | 90.15% |
| 2021 FY | 201.74 Thousand USD | 43.0% |
| 2021 Q2 | 13.47 Thousand USD | 269.93% |
| 2021 Q3 | 216.8 Thousand USD | 1509.33% |
| 2021 Q1 | -7928.00 USD | -109.96% |
| 2021 Q4 | -20.61 Thousand USD | -109.51% |
| 2020 Q1 | 40.91 Thousand USD | 155.59% |
| 2020 Q4 | 79.56 Thousand USD | 69.67% |
| 2020 FY | 141.07 Thousand USD | 139.41% |
| 2020 Q3 | 46.89 Thousand USD | 278.31% |
| 2020 Q2 | -26.29 Thousand USD | -164.27% |
| 2019 Q2 | -181.48 Thousand USD | -1117.92% |
| 2019 FY | -357.95 Thousand USD | -2238.95% |
| 2019 Q4 | -73.6 Thousand USD | 16.32% |
| 2019 Q1 | -14.9 Thousand USD | 0.0% |
| 2019 Q3 | -87.96 Thousand USD | 51.53% |
| 2018 FY | -15.3 Thousand USD | 78.9% |
| 2017 FY | -72.53 Thousand USD | -436.84% |
| 2016 FY | -13.51 Thousand USD | 66.19% |
| 2015 FY | -39.96 Thousand USD | -737.45% |
| 2014 Q1 | 51.06 Thousand USD | 0.0% |
| 2014 FY | -4772.00 USD | -131.95% |
| 2014 Q3 | 72.3 Thousand USD | 0.0% |
| 2014 Q4 | -121.79 Thousand USD | -268.45% |
| 2013 Q2 | 6608.00 USD | 138.24% |
| 2013 Q1 | -17.27 Thousand USD | 0.0% |
| 2013 FY | 14.93 Thousand USD | 0.0% |
| 2008 Q1 | -59.13 Thousand USD | 73.34% |
| 2007 Q1 | 4640.00 USD | 0.0% |
| 2007 Q4 | -221.84 Thousand USD | -1951.47% |
| 2007 Q3 | -10.81 Thousand USD | -121.87% |
| 2007 FY | -182.7 Thousand USD | -60.0% |
| 2007 Q2 | 49.44 Thousand USD | 965.6% |
| 2006 FY | -114.18 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | 69.775% |
| IR-Med Inc. | -4.9 Million USD | 95.55% |
| Polarean Imaging plc | -11.88 Million USD | 98.162% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 155.332% |
| Avitar, Inc. | -2.25 Million USD | 90.332% |
| AVITA Medical, Inc. | -39.16 Million USD | 99.442% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 81.247% |
| Össur hf. | 58.38 Million USD | 100.374% |
| Zecotek Photonics Inc. | -3.51 Million USD | 93.792% |
| QHSLab, Inc. | -468.36 Thousand USD | 53.354% |
| Wellstar International, Inc. | -3.1 Million USD | 92.972% |
| Össur hf. | 58.38 Million USD | 100.374% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 109.289% |
| Escalon Medical Corp. | -125.26 Thousand USD | -74.413% |
| Aurora Spine Corporation | -1.68 Million USD | 87.0% |
| BrainsWay Ltd. | -4.19 Million USD | 94.795% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 98.1% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | 64.009% |
| Vivos Inc. | -2.89 Million USD | 92.453% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.954% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 87.711% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | 47.738% |
| Nanomix Corporation | -12.33 Million USD | 98.229% |
| Theraclion SA | -3.67 Million USD | 94.055% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 70.986% |
| Positron Corporation | -1.63 Million USD | 86.668% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 91.728% |
| Lombard Medical, Inc. | -31.03 Million USD | 99.296% |
| ALR Technologies Inc. | -11.89 Million USD | 98.164% |
| Stratec SE | 14.42 Million USD | 101.514% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -213.485% |
| Heart Tronics, Inc. | -13.32 Million USD | 98.361% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | -74.044% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 98.443% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 99.153% |
| VMS Rehab Systems, Inc. | 46.44 USD | 470537.123% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 93.738% |
| Ingen Technologies, Inc. | -5.06 Million USD | 95.684% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 75.88% |
| United American Healthcare Corporation | 723 Thousand USD | 130.217% |
| ECGI Holdings, Inc. | -3.61 Million USD | 93.95% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 66.799% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 69.524% |
| Urologix, Inc. | -7.6 Million USD | 97.128% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 87.102% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 89.968% |
| SS Innovations International, Inc. | -20.94 Million USD | 98.957% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 72.861% |
| Smith & Nephew plc | 263 Million USD | 100.083% |
| NIOX Group Plc | 13.64 Million USD | 101.602% |
| Fuse Medical, Inc. | 1.45 Million USD | 114.964% |
| Broncus Holding Corporation | -28.09 Million USD | 99.222% |
| Brain Scientific Inc. | -12.34 Million USD | 98.23% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 99.255% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | -36.333% |